Fengli Wu

Dr. Fengli Wu

Tianjin Institute of Industrial Biotechnology, Tianjin, China
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2021 in Biotechnology for Biofuels
Verified
Journal Article
Open access
PDF file
YLYanfang Liu
Yanfang Liu
YLYuping Lin
Yuping Lin
YGYufeng Guo
Yufeng Guo
FWFengli Wu
Fengli Wu
YZYuanyuan Zhang
Yuanyuan Zhang
QWQinhong Wang
Qinhong Wang
Background: Saccharomyces cerevisiaeis widely used in traditional brewing and modern fermentation industries to produce biofuels, chemicals and other bioproducts, but challenged by various harsh industrial conditions, such as hyperosmotic, thermal and ethanol stresses. Thus, its stress tolerance enhancement has been attracting broad interests. Recently, CRISPR/Cas-based genome editing technology offers unprecedented tools to explore genetic modifications and performance improvement ofS. cerevisiae.Results: Here, we presented that the Target-AID (activation-induced cytidine deaminase) base editor of enabling C-to-T substitutions could be harnessed to generate in situ nucleotide changes on theS. cerevisiaegenome, thereby introducing protein point mutations in cells. The general transcription factor geneSPT15was targeted, and total 36 mutants with diversified stress tolerances were obtained. Among them, the 18 tolerant mutants against hyperosmotic, thermal and ethanol stresses showed more than 1.5-fold increases of fermentation capacities. These mutations were mainly enriched at the N-terminal region and the convex surface of the saddle-shaped structure of Spt15. Comparative transcriptome analysis of three most stress-tolerant (A140G, P169A and R238K) and two most stress-sensitive (S118L and L214V) mutants revealed common and distinctive impacted global transcription reprogramming and transcriptional regulatory hubs in response to stresses, and these five amino acid changes had different effects on the interactions of Spt15 with DNA and other proteins in the RNA Polymerase II transcription machinery according to protein structure alignment analysis.Conclusions: Taken together, our results demonstrated that the Target-AID base editor provided a powerful tool for targeted in situ mutagenesis inS. cerevisiaeand more potential targets of Spt15 residues for enhancing yeast stress tolerance.

4 September 2023 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
FWFengli Wu
Fengli Wu
SWShucai Wang
Shucai Wang
YPYanfeng Peng
Yanfeng Peng
YGYufeng Guo
Yufeng Guo
QWQinhong Wang
Qinhong Wang
Background: Pyruvate is a widely used value-added chemical which also serves as a hub of various metabolic pathways. The fastest-growing bacterium Vibrio natriegens is a promising chassis for synthetic biology applications with high substrate uptake rates. The aim of this study was to investigate if the high substrate uptake rates of V. natriegens enable pyruvate production at high productivities. Results: Two prophage gene clusters and several essential genes for the biosynthesis of byproducts were first deleted. In order to promote pyruvate accumulation, the key gene aceE encoding pyruvate dehydrogenase complex E1 component was down-regulated to reduce the carbon flux into the tricarboxylic acid cycle. Afterwards, the expression of ppc gene encoding phosphoenolpyruvate carboxylase was fine-tuned to balance the cell growth and pyruvate synthesis. The resulting strain PYR32 was able to produce 54.22 g/L pyruvate from glucose within 16 h, with a yield of 1.17 mol/mol and an average productivity of 3.39 g/L/h. In addition, this strain was also able to efficiently convert sucrose or gluconate into pyruvate at high titers. Conclusion: A novel strain of V. natriegens was engineered which was capable to provide higher productivity in pyruvate synthesis. This study lays the foundation for the biosynthesis of pyruvate and its derivatives in fast-growing V. natriegens.

21 March 2024 in Metabolic Engineering
Verified
Journal Article
Closed access
FWFengli Wu
Fengli Wu
SWShucai Wang
Shucai Wang
DZDan Zhou
Dan Zhou
SGShukai Gao
Shukai Gao
GSGuotian Song
Guotian Song
QWQinhong Wang
Qinhong Wang

21 July 2022 in Fermentation
Verified
Journal Article
Open access
PDF file
GSGuotian Song
Guotian Song
FWFengli Wu
Fengli Wu
YPYanfeng Peng
Yanfeng Peng
XJXiaolong Jiang
Xiaolong Jiang
QWQinhong Wang
Qinhong Wang
Catechol (CA) is an aromatic compound with important applications in the fine chemical and pharmaceutical fields. As an alternative strategy to petroleum-based chemical synthesis, the production of catechol by using microbial cell factories has attracted great interest. However, the toxicity of catechol to microbial cells significantly limits the efficient production of bio-based catechol via one-step fermentation. Therefore, in this study, a two-step strategy for the efficient synthesis of CA was designed. Protocatechuic acid (PCA) was first efficiently produced by the engineered Escherichia coli strain AAA01 via fermentation, and then PCA in the fermentative broth was converted into CA by the whole-cell biocatalyst AAA12 with PCA decarboxylase. By optimizing the expression of flavin isoprenyl transferases and protocatechuic acid decarboxylases, the titer of CA increased from 3.4 g/L to 15.8 g/L in 12 h through whole-cell biocatalysis, with a 365% improvement; after further optimizing the reaction conditions for whole-cell biocatalysis, the titer of CA achieved 17.7 g/L within 3 h, which is the highest titer reported so far. This work provides an effective strategy for the green biomanufacturing of toxic compounds by Escherichia coli cell factories.

1 September 2020 in Hellenic Journal of Cardiology
Verified
Journal Article
Open access
FZFucheng Zhang
Fucheng Zhang
SSShuhong Su
Shuhong Su
YHYuyan Hou
Yuyan Hou
LZLipei Zhao
Lipei Zhao
ZWZhifang Wang
Zhifang Wang
LZLi Zhang
Li Zhang
This study aimed to investigate the effect of ticagrelor combined with omeprazole on patients with acute myocardial infarction undergoing primary percutaneous coronary intervention (PCI). 86 patients with AMI underwent primary PCI in Xinxiang central hospital between July 2015 and December 2016 were included and divided randomly into observation group and control group by the draw, with 43 patients in each group. All patients were routinely treated with dual antiplatelet therapy with aspirin plus ticagrelor. Omeprazole was used in the observation group and placebo was used in the control group. Baseline data of patients, platelet response index (PRI) ADP-induced platelet aggregation (ADP-Ag), major adverse cardiac events (MACE), and incidence of bleeding events were recorded and compared. PRI and ADP-Ag at 7 days, 1 month, and 6 months after operation in both groups were significantly lower than those in the same group before administration (p0.05). Incidence of bleeding events in the observation group was significantly lower than that in the control group (p<0.05). For AMI patients undergoing primary PCI, omeprazole can reduce the incidence of gastrointestinal bleeding without reducing the antiplatelet aggregation effect of ticagrelor or increasing the risk of MACE, which is worthy of clinical promotion.

1 June 2023 in Biotechnology for Biofuels and Bioproducts
Verified
Journal Article
Open access
PDF file
DZDan Zhou
Dan Zhou
FWFengli Wu
Fengli Wu
YPYanfeng Peng
Yanfeng Peng
MQMuneer Ahmed Qazi
Muneer Ahmed Qazi
RLRuosong Li
Ruosong Li
QWQinhong Wang
Qinhong Wang
Background: 2-Pyrone-4,6-dicarboxylic acid (PDC), a chemically stable pseudoaromatic dicarboxylic acid, represents a promising building block for the manufacture of biodegradable polyesters. Microbial production of PDC has been extensively investigated, but low titers and yields have limited industrial applications. Results: In this study, a multi-step biosynthesis strategy for the microbial production of PDC was demonstrated using engineered Escherichia coli whole-cell biocatalysts. The PDC biosynthetic pathway was first divided into three synthetic modules, namely the 3-dehydroshikimic acid (DHS) module, the protocatechuic acid (PCA) module and the PDC module. Several effective enzymes, including 3-dehydroshikimate dehydratase for the PCA module as well as protocatechuate 4,5-dioxygenase and 4-carboxy-2-hydroxymuconate-6-semialdehyde dehydrogenase for the PDC module were isolated and characterized. Then, the highly efficient whole-cell bioconversion systems for producing PCA and PDC were constructed and optimized, respectively. Finally, the efficient multi-step biosynthesis of PDC from glucose was achieved by smoothly integrating the above three biosynthetic modules, resulting in a final titer of 49.18 g/L with an overall 27.2% molar yield, which represented the highest titer for PDC production from glucose reported to date. Conclusions: This study lays the foundation for the microbial production of PDC, including one-step de novo biosynthesis from glucose as well as the microbial transformation of monoaromatics.